226 related articles for article (PubMed ID: 17161865)
21. The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing.
Liu X; Howard KA; Dong M; Andersen MØ; Rahbek UL; Johnsen MG; Hansen OC; Besenbacher F; Kjems J
Biomaterials; 2007 Feb; 28(6):1280-8. PubMed ID: 17126901
[TBL] [Abstract][Full Text] [Related]
22. A tightly regulated and reversibly inducible siRNA expression system for conditional RNAi-mediated gene silencing in mammalian cells.
Wu RH; Cheng TL; Lo SR; Hsu HC; Hung CF; Teng CF; Wu MP; Tsai WH; Chang WT
J Gene Med; 2007 Jul; 9(7):620-34. PubMed ID: 17486668
[TBL] [Abstract][Full Text] [Related]
23. A non-covalent peptide-based strategy for siRNA delivery.
Crombez L; Charnet A; Morris MC; Aldrian-Herrada G; Heitz F; Divita G
Biochem Soc Trans; 2007 Feb; 35(Pt 1):44-6. PubMed ID: 17233597
[TBL] [Abstract][Full Text] [Related]
24. Functional gene silencing mediated by chitosan/siRNA nanocomplexes.
Ji AM; Su D; Che O; Li WS; Sun L; Zhang ZY; Yang B; Xu F
Nanotechnology; 2009 Oct; 20(40):405103. PubMed ID: 19752491
[TBL] [Abstract][Full Text] [Related]
25. Exploring cell type-specific internalizing antibodies for targeted delivery of siRNA.
Liu B
Brief Funct Genomic Proteomic; 2007 Jun; 6(2):112-9. PubMed ID: 17670766
[TBL] [Abstract][Full Text] [Related]
26. Chitosan as a carrier for targeted delivery of small interfering RNA.
Rudzinski WE; Aminabhavi TM
Int J Pharm; 2010 Oct; 399(1-2):1-11. PubMed ID: 20732398
[TBL] [Abstract][Full Text] [Related]
27. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity.
Akhtar S; Benter I
Adv Drug Deliv Rev; 2007 Mar; 59(2-3):164-82. PubMed ID: 17481774
[TBL] [Abstract][Full Text] [Related]
28. Targeted siRNA delivery by anti-HER2 antibody-modified nanoparticles of mPEG-chitosan diblock copolymer.
Wang Y; Liu P; Du J; Sun Y; Li F; Duan Y
J Biomater Sci Polym Ed; 2013; 24(10):1219-32. PubMed ID: 23713424
[TBL] [Abstract][Full Text] [Related]
29. RNA interference by nanofiber-based siRNA delivery system.
Cao H; Jiang X; Chai C; Chew SY
J Control Release; 2010 Jun; 144(2):203-12. PubMed ID: 20138939
[TBL] [Abstract][Full Text] [Related]
30. [Downregulation of HER2 by adenovirus-mediated RNA interference and its inhibitory effect on growth of SKBR3 breast cancer cell].
Cheng LS; Zha Z; Xi JJ; Jiang B; Liu J; Yao XB
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Aug; 23(8):691-5. PubMed ID: 17618556
[TBL] [Abstract][Full Text] [Related]
31. Hyaluronic acid complexed to biodegradable poly L-arginine for targeted delivery of siRNAs.
Kim EJ; Shim G; Kim K; Kwon IC; Oh YK; Shim CK
J Gene Med; 2009 Sep; 11(9):791-803. PubMed ID: 19569085
[TBL] [Abstract][Full Text] [Related]
32. Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy.
Takahashi Y; Nishikawa M; Takakura Y
Adv Drug Deliv Rev; 2009 Jul; 61(9):760-6. PubMed ID: 19386274
[TBL] [Abstract][Full Text] [Related]
33. [Inhibition of invasive and chemotactic abilities of SKOV3 cells by human epithelial growth receptor-2 small interfering RNA].
Zhang SL; Lu YM; Meng LR; Zhao YY
Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):48-53. PubMed ID: 17331422
[TBL] [Abstract][Full Text] [Related]
34. [Chitosan-siRNA complex nanoparticles for gene silencing].
Liu X
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Feb; 27(1):97-101. PubMed ID: 20337033
[TBL] [Abstract][Full Text] [Related]
35. Development of poly(amino ester glycol urethane)/siRNA polyplexes for gene silencing.
Tseng SJ; Tang SC
Bioconjug Chem; 2007; 18(5):1383-90. PubMed ID: 17567100
[TBL] [Abstract][Full Text] [Related]
36. Delivery of siRNA from lyophilized polymeric surfaces.
Andersen MØ; Howard KA; Paludan SR; Besenbacher F; Kjems J
Biomaterials; 2008 Feb; 29(4):506-12. PubMed ID: 17950838
[TBL] [Abstract][Full Text] [Related]
37. Growth inhibition of breast cancer cell line MCF-7 by siRNA silencing of Wilms tumor 1 gene.
Navakanit R; Graidist P; Leeanansaksiri W; Dechsukum C
J Med Assoc Thai; 2007 Nov; 90(11):2416-21. PubMed ID: 18181329
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of HER2/neu receptor by solamargine enhances anticancer drug-mediated cytotoxicity in breast cancer cells with high-expressing HER2/neu.
Shiu LY; Liang CH; Huang YS; Sheu HM; Kuo KW
Cell Biol Toxicol; 2008 Jan; 24(1):1-10. PubMed ID: 17885815
[TBL] [Abstract][Full Text] [Related]
39. High transfection efficiency of quantum dot-antisense oligonucleotide nanoparticles in cancer cells through dual-receptor synergistic targeting.
Zhang MZ; Li C; Fang BY; Yao MH; Ren QQ; Zhang L; Zhao YD
Nanotechnology; 2014 Jun; 25(25):255102. PubMed ID: 24896735
[TBL] [Abstract][Full Text] [Related]
40. Barriers to successful delivery of short interfering RNA after systemic administration.
White PJ
Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1371-6. PubMed ID: 18565190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
